LPL Financial’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-37,980
Closed -$66.5K 5671
2025
Q1
$66.5K Sell
37,980
-12,000
-24% -$15.8K ﹤0.01% 5116
2024
Q4
$79K Sell
49,980
-8,000
-14% -$12.3K ﹤0.01% 5036
2024
Q3
$91K Buy
57,980
+11,000
+23% +$18.2K ﹤0.01% 4912
2024
Q2
$83.9K Sell
46,980
-66,500
-59% -$154K ﹤0.01% 4768
2024
Q1
$327K Buy
+113,480
New +$185K ﹤0.01% 4133
2023
Q3
Sell
-18,502
Closed -$27.2K 4777
2023
Q2
$27.2K Buy
18,502
+5,000
+37% +$6.66K ﹤0.01% 4490
2023
Q1
$11.4K Buy
+13,502
New +$17.9K ﹤0.01% 4447
2016
Q1
Sell
-195
Closed -$202K 3188
2015
Q4
$202K Buy
195
+98
+101% +$98.2K ﹤0.01% 2816
2015
Q3
$76K Sell
97
-46
-32% -$47.2K ﹤0.01% 2682
2015
Q2
$176K Sell
143
-8
-5% -$12.9K ﹤0.01% 2664
2015
Q1
$316K Sell
151
-8
-5% -$17.4K ﹤0.01% 2204
2014
Q4
$306K Buy
159
+8
+5% +$14.2K ﹤0.01% 2140
2014
Q3
$121K Buy
151
+1
+0.7% +$846 ﹤0.01% 2582
2014
Q2
$145K Sell
150
-158
-51% -$135K ﹤0.01% 2561
2014
Q1
$334K Buy
+308
New +$341K ﹤0.01% 2062

Other funds holding RGLS